- Home
- INNV vs KURA Comparison
INNV vs KURA Comparison
Compare INNV & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INNV
- KURA
- Stock Information
- Founded
- INNV 2007
- KURA 2014
- Country
- INNV United States
- KURA United States
- Employees
- INNV N/A
- KURA N/A
- Industry
- INNV Medical/Nursing Services
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INNV Health Care
- KURA Health Care
- Exchange
- INNV Nasdaq
- KURA Nasdaq
- Market Cap
- INNV 527.9M
- KURA 561.9M
- IPO Year
- INNV 2021
- KURA N/A
- Fundamental
- Price
- INNV $3.84
- KURA $5.60
- Analyst Decision
- INNV Sell
- KURA Strong Buy
- Analyst Count
- INNV 2
- KURA 12
- Target Price
- INNV $5.00
- KURA $24.50
- AVG Volume (30 Days)
- INNV 33.9K
- KURA 1.3M
- Earning Date
- INNV 05-06-2025
- KURA 08-07-2025
- Dividend Yield
- INNV N/A
- KURA N/A
- EPS Growth
- INNV N/A
- KURA N/A
- EPS
- INNV N/A
- KURA N/A
- Revenue
- INNV $831,683,000.00
- KURA $67,991,000.00
- Revenue This Year
- INNV $13.77
- KURA $109.86
- Revenue Next Year
- INNV $10.12
- KURA $107.90
- P/E Ratio
- INNV N/A
- KURA N/A
- Revenue Growth
- INNV 12.19
- KURA N/A
- 52 Week Low
- INNV $2.60
- KURA $5.41
- 52 Week High
- INNV $6.69
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- INNV 44.28
- KURA 37.63
- Support Level
- INNV $3.75
- KURA $5.73
- Resistance Level
- INNV $4.02
- KURA $6.01
- Average True Range (ATR)
- INNV 0.21
- KURA 0.29
- MACD
- INNV -0.03
- KURA -0.08
- Stochastic Oscillator
- INNV 23.53
- KURA 1.57
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.